Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2025-07-02 00:00:00 ET · period of report 2025-06-30 · accession 0001437749-25-022020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-02 | 2025-06-30 | BKYI | Sullivan James David | CLO, SVP Strategy, Compliance | A - Grant | $0.7 | +139 | 44.9K | +0.3% | +$97.30 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-30 | A | A | 139 | $0.7 | 44,851 | D | — | — | (F2) Holdings do not include options to purchase 174 shares and 12,667 shares issuable upon exercise of warrants. |